hCG
Human chorionic gonadotropin
hCG is a glycoprotein hormone. Medicines such as PREGNYL are used in selected endocrine and reproductive settings.
Approvals
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
hCG is a defined glycoprotein hormone. Approved information applies to PREGNYL and its indication-specific use in international units.
- Human research
- Strong
- Replication
- No independent replication
- Clinical endpoints
- Hard patient-relevant outcomes
- Safety
- Characterized by prescribing information or extensive studies
- Approval
- US · Approved
The dimensions are presented separately and are not combined into an overall score.
What the source shows
The label describes indication-specific uses, not a universal “PCT” protocol.
- PREGNYL: US prescribing informationPrescribing information2025
U.S. National Library of Medicine (DailyMed)
Accessed:
Research gaps
- ·Extrapolation to self-designed hormone cycles is not established.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
hCG exerts LH-like effects on the gonads.
- PREGNYL: US prescribing informationPrescribing information2025
U.S. National Library of Medicine (DailyMed)
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Reported adverse effects
- ·Risks include hypersensitivity and, during ovarian stimulation, hyperstimulation syndromes.
Contraindications and warnings
- ·PREGNYL is contraindicated in precocious puberty, androgen-dependent tumors and hypersensitivity; the full label remains product- and indication-specific.
Interactions
- ·The PREGNYL label does not establish drug interactions; that does not establish safety for unstudied combinations.
Research gaps
- ·Extrapolation to self-designed hormone cycles is not established.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- PREGNYL: US prescribing informationPrescribing information2025
U.S. National Library of Medicine (DailyMed)
Accessed:
Sources
Sources checked: · Version 2
- PREGNYL: US prescribing informationPrescribing information2025
U.S. National Library of Medicine (DailyMed)
Accessed: